I think less than a year for FDA Remplir approval Speckled. They passed the 510K pilot animal study in April 2021. If its another year from here, that would be a disgrace. Suspect the upcoming 24 month full Remplir nerve results will provide a basis for some sort of fast-track approval with the FDA, particularly given they are TGA approved and had already met the FDA's pre-requisites for 510K (I think not just taking 510K a strategic error, but hopefully they prove me wrong).
OCC Trading, page-959
Add OCC (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
35.5¢ |
Change
-0.005(1.39%) |
Mkt cap ! $74.31M | |||
| Open | High | Low | Value | Volume |
| 36.0¢ | 36.0¢ | 35.5¢ | $57.4K | 161.6K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 11 | 142866 | 35.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 35.5¢ | 27779 | 1 |
View Market Depth
| Last trade - 12.37pm 08/07/2024 (20 minute delay) ? |
| OCC (ASX) Chart |